California State Teachers Retirement System (CalSTRS)’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.8K | Sell |
1,285
-3,680
| -74% | -$16.4K | ﹤0.01% | 2423 |
|
|
2026
Q1 | $18.6K | Sell |
4,965
-684
| -12% | -$2.31K | ﹤0.01% | 2469 |
|
|
2025
Q4 | $17K | Sell |
5,649
-19
| -0.3% | -$48 | ﹤0.01% | 2585 |
|
|
2025
Q3 | $10.8K | Buy |
5,668
+4
| +0.1% | +$7 | ﹤0.01% | 2806 |
|
|
2025
Q2 | $8.04K | Buy |
+5,664
| New | +$7.67K | ﹤0.01% | 2809 |
|
|
2024
Q2 | – | Sell |
-6,982
| Closed | -$8.66K | – | 3087 |
|
|
2024
Q1 | $8.66K | Sell |
6,982
-48,577
| -87% | -$57.9K | ﹤0.01% | 2936 |
|
|
2023
Q4 | $58.3K | Sell |
55,559
-3,488
| -6% | -$10.6K | ﹤0.01% | 2560 |
|
|
2023
Q3 | $404K | Sell |
59,047
-8,054
| -12% | -$68.8K | ﹤0.01% | 2306 |
|
|
2023
Q2 | $696K | Buy |
67,101
+2,076
| +3% | +$18.8K | ﹤0.01% | 2132 |
|
|
2023
Q1 | $526K | Sell |
65,025
-1,299
| -2% | -$16.5K | ﹤0.01% | 2285 |
|
|
2022
Q4 | $1.04M | Buy |
66,324
+708
| +1% | +$11.4K | ﹤0.01% | 1866 |
|
|
2022
Q3 | $1.03M | Buy |
65,616
+3,618
| +6% | +$57K | ﹤0.01% | 1867 |
|
|
2022
Q2 | $865K | Buy |
61,998
+1,012
| +2% | +$14.2K | ﹤0.01% | 2056 |
|
|
2022
Q1 | $1.05M | Sell |
60,986
-5,474
| -8% | -$74.7K | ﹤0.01% | 2007 |
|
|
2021
Q4 | $966K | Buy |
66,460
+2,639
| +4% | +$40K | ﹤0.01% | 2180 |
|
|
2021
Q3 | $1.15M | Buy |
63,821
+3,925
| +7% | +$62.9K | ﹤0.01% | 2055 |
|
|
2021
Q2 | $1.05M | Buy |
+59,896
| New | +$1.36M | ﹤0.01% | 2185 |
|
|
2020
Q2 | – | Sell |
-47,336
| Closed | -$49K | – | 3020 |
|
|
2020
Q1 | $49K | Buy |
47,336
+549
| +1% | +$747 | ﹤0.01% | 2916 |
|
|
2019
Q4 | $88K | Sell |
46,787
-653
| -1% | -$1.08K | ﹤0.01% | 2938 |
|
|
2019
Q3 | $51K | Hold |
47,440
| – | – | ﹤0.01% | 2988 |
|
|
2019
Q2 | $104K | Sell |
47,440
-7,973
| -14% | -$43.5K | ﹤0.01% | 2977 |
|
|
2019
Q1 | $332K | Hold |
55,413
| – | – | ﹤0.01% | 2532 |
|
|
2018
Q4 | $410K | Buy |
55,413
+14,509
| +35% | +$150K | ﹤0.01% | 2404 |
|
|
2018
Q3 | $594K | Sell |
40,904
-3
| -0% | -$51 | ﹤0.01% | 2356 |
|
|
2018
Q2 | $817K | Buy |
40,907
+5,643
| +16% | +$104K | ﹤0.01% | 2180 |
|
|
2018
Q1 | $618K | Sell |
35,264
-1,381
| -4% | -$29.3K | ﹤0.01% | 2263 |
|
|
2017
Q4 | $904K | Buy |
36,645
+587
| +2% | +$14.3K | ﹤0.01% | 2060 |
|
|
2017
Q3 | $931K | Buy |
36,058
+362
| +1% | +$9.7K | ﹤0.01% | 2049 |
|
|
2017
Q2 | $968K | Buy |
35,696
+13,500
| +61% | +$367K | ﹤0.01% | 2082 |
|
|
2017
Q1 | $662K | Sell |
22,196
-1,100
| -5% | -$31.7K | ﹤0.01% | 2322 |
|
|
2016
Q4 | $632K | Buy |
23,296
+3,200
| +16% | +$81.6K | ﹤0.01% | 2392 |
|
|
2016
Q3 | $515K | Buy |
20,096
+1,200
| +6% | +$25.5K | ﹤0.01% | 2480 |
|
|
2016
Q2 | $349K | Buy |
18,896
+6,683
| +55% | +$132K | ﹤0.01% | 2664 |
|
|
2016
Q1 | $231K | Buy |
12,213
+1,563
| +15% | +$29.9K | ﹤0.01% | 2767 |
|
|
2015
Q4 | $287K | Buy |
+10,650
| New | +$207K | ﹤0.01% | 2730 |
|
Other funds holding ACRS
RCM
BCM
DTC
VC
FLSM
RSCM
DC
California State Teachers Retirement System (CalSTRS)'s ACRS Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Aclaris Therapeutics (ACRS) stake by 74% in Q2 2026, selling an estimated $16.4K and leaving 1,285 shares worth $6.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.
California State Teachers Retirement System (CalSTRS) first reported a position in ACRS in Q4 2015 and has held it in 35 quarters since. The position peaked at $1.15M in Q3 2021. 149 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 1,285 shares of Aclaris Therapeutics worth $6.8K as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 3,680 Aclaris Therapeutics shares in Q2 2026, an estimated $16.4K.
- Aclaris Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2423 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Aclaris Therapeutics in Q4 2015 and has held it in 35 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Aclaris Therapeutics position peaked at $1.15M in Q3 2021.
- 149 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.